Join our mailing list and receive the monthly BioVox newsletter for free!

RELATED ARTICLES
Nuclear technology saves lives, especially in Belgium!

Nuclear energy has become a part of our every day lives, but not solely for electricity production. Over the last century, nuclear technology has …


KU Leuven students develop winning device to detect kidney failure

A team of fourteen KU Leuven students has built a diagnostic device that can analyze the blood of kidney patients in five minutes. It’s a fast, in…


Diagnosis on your smartphone!

Belgium’s first-ever mHealth Hackathon event took place in Brussels between March 18-20, 2016. Armed with breakthrough ideas and backed up by caff…

POPULAR TAGS

Unchained Labs acquires Trinean

Written by LVS on in the category news with the tags , .


Lab device developer Unchained Labs has announced its acquisition of Belgian company Trinean. Trinean made waves in the lab devices sector with its DropSense system, which measures protein, DNA and RNA concentration in minute biologics and genomics samples. The transaction makes for Unchained Labs’ 5th acquisition in just over 2 years.

DropSense96 is the only system on the market that can measure up to 96 high concentration protein samples in 5 minutes. Scientists simply load 2 microliters of sample into the proprietary DropPlate and enter it into the system. DropSense systems are a completely worry-free way to measure concentrations — no need to dilute or mix samples, clean anything before or after a run, or calibrate the system.

Philippe Stas, CEO of Trinean, comments:
“Since we started 10 years ago, Trinean has made micro-volume concentration measurements higher throughput and more accessible to life science researchers. Unchained Labs is the ideal home for DropSense and this acquisition is great for our customers, partners and employees.”

Tim Harkness, Founder and CEO of Unchained Labs says:
“These products are a perfect strategic fit for Unchained Labs. Concentration measurement is central to everything our customers do and DropSense96 is the only product in the world that does it for biologics at high concentration with high-throughput."

In just over 2 years, Unchained Labs has grown to over 130 employees, $35M+ in revenue, 8 product lines and has direct distribution around the world. In connection with this transaction, the company raised $13M in a Series C financing. The original syndicate partners, Novo Ventures, Canaan Partners and TPG Biotech all participated in the financing.

Read more about: , .

RELATED ARTICLES
Nuclear technology saves lives, especially in Belgium!

Nuclear energy has become a part of our every day lives, but not solely for electricity production. Over the last century, nuclear technology has …


KU Leuven students develop winning device to detect kidney failure

A team of fourteen KU Leuven students has built a diagnostic device that can analyze the blood of kidney patients in five minutes. It’s a fast, in…


Diagnosis on your smartphone!

Belgium’s first-ever mHealth Hackathon event took place in Brussels between March 18-20, 2016. Armed with breakthrough ideas and backed up by caff…

POPULAR TAGS

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

Biowin GSK Turnstone KU Leuven Flanders.bio Janssen XpandInnovation UGent Itera Life Science V-Bio Ventures

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.